GC
EXAS

Gratus Capital’s Exact Sciences EXAS Stock Holding History

Gratus Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$211K Hold
5,000
– – 0.01% 341
2024
Q1 		$345K Hold
5,000
– – 0.02% 263
2023
Q4 		$370K Hold
5,000
– – 0.02% 207
2023
Q3 		$341K Hold
5,000
– – 0.02% 204
2023
Q2 		$470K Hold
5,000
– – 0.03% 177
2023
Q1 		$339K Buy
+5,000
New +$321K 0.03% 179

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Gratus Capital's EXAS Position: Q2 2024 in Review

Gratus Capital held its Exact Sciences (EXAS) position steady in Q2 2024 at 5,000 shares worth $211K. The position accounts for 0.01% of the portfolio, ranked #341.

Gratus Capital first reported a position in EXAS in Q1 2023 and has held it in 6 quarters since. The position peaked at $470K in Q2 2023. 542 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Gratus Capital held 5,000 shares of Exact Sciences worth $211K as of Q2 2024.
  • Gratus Capital left its Exact Sciences share count unchanged in Q2 2024.
  • Exact Sciences made up 0.01% of Gratus Capital's portfolio in Q2 2024, its #341 holding.
  • Gratus Capital first reported a position in Exact Sciences in Q1 2023 and has held it in 6 quarters since.
  • Gratus Capital's Exact Sciences position peaked at $470K in Q2 2023.
  • 542 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Gratus Capital's 13F filing for Q2 2024, filed 25 Jul 2024.